BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31433499)

  • 1. Metamizole (Dipyrone) and the Liver: A Review of the Literature.
    Lutz M
    J Clin Pharmacol; 2019 Nov; 59(11):1433-1442. PubMed ID: 31433499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recall of metamizole from the market in countries with modern pharmacotherapy].
    Mihajlović G
    Srp Arh Celok Lek; 1996; 124(1-2):44-6. PubMed ID: 9102814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Maj S; Centkowski P
    Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmasking of Metamizole-induced Liver Injury by Simult aneous Development of Characteristic Agranulocytosis.
    Lutz M; Grünewald I; Lenze F; Heinzow H; Ullerich H; Kabar I; Schmidt HH; Tepasse PR
    Curr Drug Saf; 2023; 18(3):404-412. PubMed ID: 35670337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
    Klose S; Pflock R; König IR; Linder R; Schwaninger M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metamizol: current status in Dutch practice].
    van Diepen ATN; Simons P; Bos JM; Kramers C
    Ned Tijdschr Geneeskd; 2022 Jan; 166():. PubMed ID: 35138735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
    Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
    Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of metamizole: a systematic review of the literature.
    Andrade S; Bartels DB; Lange R; Sandford L; Gurwitz J
    J Clin Pharm Ther; 2016 Oct; 41(5):459-77. PubMed ID: 27422768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users.
    Hedenmalm K; Pacurariu A; Slattery J; Kurz X; Candore G; Flynn R
    Drug Saf; 2021 Sep; 44(9):973-985. PubMed ID: 34273099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible increased risk of metamizole-associated neutropenia among COVID-19 patients.
    Lerman TT; Sagi M; Shafir Y; Sheena L; Cohen E; Goldberg E; Krause I
    Br J Clin Pharmacol; 2021 Jul; 87(7):2902-2906. PubMed ID: 33332642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric Agranulocytosis Associated with Metamizole Treatment.
    Kılıç Ö; İşeri Nepesov M; Ulukapı HB; Özdemir ZC; Bör Ö; Dinleyici EÇ
    Paediatr Drugs; 2021 Jan; 23(1):105-110. PubMed ID: 33247375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
    Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D; Trpković A; Cvetković Z
    Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
    Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
    Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology of non-opioid analgesics].
    Schneider J; Kreutz R; Bolbrinker J
    Schmerz; 2019 Apr; 33(2):165-179. PubMed ID: 30535850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.
    Allgaier R; Kandulski A; Gülow K; Maier L; Müller M; Tews HC
    Drugs R D; 2023 Jun; 23(2):93-98. PubMed ID: 36988798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characteristics of metamizole.
    Jasiecka A; Maślanka T; Jaroszewski JJ
    Pol J Vet Sci; 2014; 17(1):207-14. PubMed ID: 24724493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of metamizole sodium-induced agranulocytosis in Poland.
    Maj S; Lis Y
    J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.